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ABSTRACT 
Author: Luther, Lauren. PhD 
Institution: Purdue University 
Degree Received: August 2019 
Title: Mobile Enhancement of Motivation in Schizophrenia: A Pilot Trial of a Personalized Text-
Message Intervention for Motivation Deficits.  
Committee Chair: Michelle P. Salyers 
 
Motivation deficits remain an unmet treatment need in schizophrenia. Recent preclinical research 
has identified novel mechanisms underlying motivation deficits, namely impaired effort-cost 
computations and reduced future reward-value representation maintenance, that may serve as 
more effective treatment targets to improve motivation. The main aim of this study was to test 
the feasibility and preliminary effectiveness of a translational mechanism-based intervention, 
MEMS (Mobile Enhancement of Motivation in Schizophrenia), which leverages mobile 
technology to target these mechanisms with text-messages. Fifty-six participants with a 
schizophrenia-spectrum disorder were randomized to MEMS (n = 27) or a control condition (n = 
29). All participants set recovery goals to complete over eight-weeks. The MEMS group also 
received personalized, interactive text-messages each weekday to support motivation. Retention 
and engagement in MEMS was high: 92.6% completed 8 weeks of MEMS, with an 86.1% text-
message response rate, and 100% reported that they were satisfied with the text-messages. 
Compared to the control condition, the MEMS group had significantly greater improvements in 
interviewer-rated motivation and anticipatory pleasure and obtained significantly more recovery-
oriented goals at the end of the 8-week period. There were no significant group differences in 
performance-based effort-cost computations and future reward-value representations, self-
reported motivation, quality of life, functioning, or additional secondary outcomes of positive 
symptoms, mood symptoms, or neurocognition. Results suggest that MEMS is feasible as a 
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relatively brief, low-intensity mobile intervention that could effectively improve interviewer-
rated motivation, anticipatory pleasure, and recovery goal attainment in those with 
schizophrenia-spectrum disorders.  
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INTRODUCTION 
Schizophrenia is a severe mental illness (SMI), accounting for over 60 billion dollars in 
treatment costs and lost wages each year in the U.S. alone.1 Research suggests that motivation 
deficits are a key factor affecting functional disability in people with schizophrenia.2,3 Indeed, 
motivation reductions have demonstrated cross-sectional and longitudinal links to poorer 
functioning and quality of life4-7 and are barriers to obtaining meaningful life goals that can 
facilitate recovery.8 Yet motivation deficits remain an unmet clinical need,9 as most psychosocial 
and pharmacological interventions have demonstrated limited efficacy in ameliorating these 
symptoms.7,10 One barrier in the development of improved treatments to address these symptoms 
is a limited understanding of the precise mechanisms underlying motivation deficits in people 
with schizophrenia.  
A burgeoning area of preclinical and human behavioral research has identified several 
reward-processing mechanisms underlying motivation deficits in schizophrenia. Specifically, a 
recent body of work has found that people with schizophrenia exhibit two related mechanisms 
that are posited to underlie motivation deficits: 1) impaired effort-cost computations and 2) 
reduced maintenance of reward-value representations.11,12 Broadly, effort-cost computations 
associated with a task or action involve multiple processes, including generating a representation 
of the perceived effort (or cost such as energy or time) to complete the task, generating a 
representation of the benefits or rewards linked to completing the task, including identifying the 
magnitude of the reward and probability of reward receipt,13 and then integrating this 
information to evaluate whether the reward is worth the effort.11 To assess effort-cost 
computations, researchers have created tasks that assess whether a subject is willing to exert 
more effort for high versus relatively low magnitude rewards. Initial effort-cost computation 
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work stemmed primarily from animal model research highlighting the role of mesolimbic 
dopamine systems in effort-cost computations and in modulating the amount of effort an animal 
will exert for high versus low magnitude rewards.14-16 Most notably, Kellendonk and 
colleagues17 created an animal model of negative symptoms by genetically altering mice to 
selectively overexpress striatal D2 receptors (D2R-OE); these mice showed intact hedonic 
reactions to immediate rewards but impaired effort-cost computations whereby when they were 
given the option to allocate little or no effort for a low magnitude food reward or exert greater 
effort (lever presses) for a higher magnitude and preferred food reward, the D2R-OE mice were 
less willing than control mice to choose to exert greater effort for the preferred reward.18 Further, 
these D2R-OE mice also showed reduced sensitivity to a valued future food reward, suggesting 
that these mice also had difficulty representing the value of future rewards.18 Together, these 
results suggest that impaired mesolimbic dopamine systems, which have also been implicated in 
humans with schizophrenia, may yield specific behavioral mechanisms that contribute to 
reductions in motivated behavior: effort-cost computations and future reward-value 
representations.  
Building on these preclinical studies, researchers have adapted animal paradigms to 
assess effort cost-computations in humans. Much of this work has centered around the 
translational Effort Expenditure for Rewards Task (EEfRT19), which asks participants to choose 
between completing an easy physical effort task that provides low monetary rewards or a 
relatively harder physical effort task that provides greater monetary rewards on a series of trials. 
Further, the probability of receiving the monetary rewards if the chosen task is successfully 
completed varies across trials. On this task, compared to controls, people with schizophrenia are 
less likely to choose the hard effort option on trials where the rewards and probability of 
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receiving the rewards are highest20-24 but select about the same amount20,24 or even more22,23 hard 
effort options than controls on trials with lower reward receipt probability and magnitude. 
Together, this suggests that people with schizophrenia allocate less effort on maximally 
rewarding tasks, or in other words, display impaired or inefficient effort-cost computations, 
especially on trials when it would be most advantageous to put forth more effort. Further, this 
also suggests that participants with schizophrenia have difficulty translating reward related cues 
(magnitude, probability) to guide their decisions about when it might be most beneficial to 
allocate effort. Importantly, several studies have found that greater motivation deficits or 
negative symptoms are associated with choosing fewer hard tasks on the EEfRT, particularly in 
the high reward, high probability conditions.20,22,25 Thus, these studies in humans corroborate 
findings from the preclinical studies and further suggest that motivational deficits may reflect 
difficulty integrating information about the cost (i.e., effort) and reward (magnitude, probability) 
of a task to identify when it is most advantageous to allocate effort.21,23  
Relatedly, work in people with schizophrenia has also identified that motivational deficits 
appear to be linked to deficits in representing and maintaining (i.e., ‘hold in mind’26) mental 
representations of the value of future rewards over time.11,12 More specifically, temporally distant 
rewards such as getting a degree may be more poorly represented and become undervalued, 
especially compared to more immediate rewards, because of difficulty generating and 
maintaining internal representations of the value of future rewards needed to guide long-term 
behavior or goal-attainment.27 Indeed, many with schizophrenia have difficulty sustaining effort 
for long-term goals or engagement in vocational or educational training programs,28,29 especially 
when the associated rewards are temporally distant (e.g., paycheck, degree). Research has also 
shown that rewards that are immediately provided impact behavior to a greater degree than 
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internal representations of rewards in those with schizophrenia.30 Further, using a delay 
discounting task, several studies have found that schizophrenia participants discount the value of 
future rewards more steeply than healthly controls,27,31-33 suggesting that people with 
schizophrenia have greater difficulty representing and thus devalue future rewards. Notably, 
Heerey et al.27 have also found that greater difficulty representing future rewards (e.g., greater 
discounting) was related to reduced motivation. Further, others have found that value 
maintenance even over a brief time period is impaired and associated with reduced motivation in 
schizophrenia.26 Thus, motivational impairments in schizophrenia appear to relate to difficulties 
in identifying and maintaining reward-value representations over time that are needed to guide 
and support long-term goal-directed behavior.  
Although these results provide converging evidence that both impaired effort-cost 
computations and reduced value representations of future rewards are specific underlying 
mechanisms that contribute to reduced motivated behavior in animal and human research, work 
is needed to identify whether targeting these mechanisms in psychosocial treatments will help to 
ameliorate motivation deficits in people with schizophrenia. Thus, the current study aimed to 
translate these findings into a novel mechanism-based psychosocial intervention for motivation 
deficits. Specifically, I aimed to leverage mobile technology to target these mechanisms in real-
time, real-world settings. Indeed, effort-cost computations are made throughout a person’s daily 
life (e.g., making favorite meal from scratch versus making a frozen meal version), and mobile 
interventions can provide real-time services to support adaptative effort-cost computations. 
Mobile interventions can be used to guide effective effort allocation by helping to cue and 
reinforce engagement in high-effort but high-reward tasks (e.g., looking/applying for jobs 
involving animals) that are important to meaningful long term-goals (e.g., becoming a veterinary 
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technician). Further, mobile interventions can be used to provide frequent reminders to promote 
and maintain reward-value maintenance associated with different goals in order to guide 
behavior to support long-term goal attainment.11 Thus, mobile interventions may provide real-
time guidance in a person’s naturalistic environment to target both effort-cost computations and 
maintenance of future reward-value representations in order to improve motivation.  
Extant studies have found that mobile interventions are feasible, acceptable, and 
clinically-promising tools to support a range of outcomes in people with schizophrenia. 
Participants receiving daily text-messages targeting symptom management and monitoring, 
medication adherence, and/or socialization have generally reported high levels of satisfaction and 
utility with text-messages.34-36 Further, participant retention and response rates to text-messages 
in seven or 12-week studies with schizophrenia samples have been high,34,35,37 supporting the 
feasibility of this approach. Moreover, initial studies have demonstrated that text-message 
interventions are potentially effective in improving a range of targeted domains, including 
medication adherence, positive symptoms, and social functioning.34,37-39  
Despite these promising results, few studies have used mobile interventions to target 
motivation deficits or other negative symptoms directly. To date, I am aware of only one study 
that has targeted motivation. Schlosser et al.40 used a mobile app-based intervention for people 
with early psychosis and found that the 12-week intervention led to trend improvements in self-
reported motivation/pleasure symptoms but no significant changes in clinician-rated negative 
symptoms, functioning, or quality of life. Further, mobile interventions targeting other domains 
have found limited effectiveness for improving motivation or negative symptoms more 
broadly.34,41 In addition, studies of mobile interventions, particularly text-message interventions, 
generally have yet to move beyond feasibility studies, and others have pointed to the need for 
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more rigorous randomized designs.42 An additional limitation of extant studies is that many 
provide participants study cell-phones only for the duration of the mobile intervention, which 
reduces the ecological validity and clinical utility of these findings. 
 To address these gaps, this study tests the feasibility and initial effectiveness of a mobile 
text-message intervention, MEMS (Mobile Enhancement of Motivation in Schizophrenia), aimed 
at improving motivation by targeting effort-cost computations and future reward-value 
representation maintenance. To more rigorously test the intervention, I used a randomized design 
to identify whether text-messages would lead to improvements in outcomes above the effects of 
a group who engaged in a single goal-setting session. I chose goal-setting as the comparator 
because it is a common method to target motivation in psychosocial interventions.43,44 I 
hypothesized that MEMS would lead to greater improvements in primary outcomes of effort-cost 
computations, value representations of future rewards, clinician-rated and self-reported 
motivation, and overall goal attainment compared to goal-setting alone. I also explored whether 
there were group differences in secondary outcomes of quality of life, functioning, 
neurocognition, and other symptoms (positive, mood, and additional negative symptoms). 
Further, given that most prior schizophrenia mobile intervention studies provide study cell-
phones, I also aimed to test the feasibility of solely using personal mobile phones to deliver text-
message interventions, as well as engagement (i.e., response rate), usability, and satisfaction with 
MEMS.  
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METHOD 
Participants 
Participants were recruited from a community mental health center that serves outpatients 
with SMI. Interested participants were given a study overview and completed a phone screen to 
identify if they 1) were ≥ 18 years old, 2) had been diagnosed with a schizophrenia-spectrum 
disorder, 3) owned a mobile phone that could send/receive text-messages, and 4) would permit 
study staff to send text-messages to their phone. Eligible participants then completed an initial 
in-person interview after providing informed consent. Diagnoses were confirmed with the 
Structured Clinical Interview for DSM-5 (SCID-545), and participants were enrolled if they also 
1) demonstrated ≥ a fourth grade reading level on the Graded Word List,46 2) were in a post-
acute illness phase as indexed by no past month inpatient hospitalizations or medication changes; 
3) had ≥ moderate motivation deficits according to the Clinical Assessment Interview for 
Negative Symptoms (CAINS)47 in at least one domain: motivaiton for family, close friends and 
romantic relationships, work and school, and/or recreational acitivities. Ineligible participants 
were compensated $10. Eligible participants completed additional study measures and a goal-
setting session where they set recovery-oriented goals to complete over eight weeks. After the 
goal-setting session, participants were randomized (see supplemental methods for randomization 
details) to also receive either 1) MEMS or 2) no additional study intervention (referred to 
hereafter as the control group). Follow-up assessments were completed at the end of the eight-
week period. Participants were compensated $40 for completing each assessment and had the 
opportunity to win an additional $2 to $8.24 on a study task (see below) at both assessments. 
Following a prior study using personal cell-phones,35 I reimbursed participants for text-message 
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costs ($30 per month); however, to ensure that this additional monetary reimbursement was not 
influencing participant outcomes, both groups received this compensation. Study procedures 
were approved by the local institutional review board.  
Goal-Setting Session 
After completing study assessments, all participants engaged in a goal-setting session 
where they set specific, measurable, achievable, realistic, and timed (SMART48,49) recovery 
goals to complete over eight-weeks. The goal-setting session incorporated techniques from 
Collaborative Goal Technology (GCT43), a systematic, evidence-based recovery goal-setting 
method focused on identifying the value, importance, and meaning of a goal.8 See supplemental 
methods for additional goal-setting details.  
MEMS 
In line with prior text-message intervention studies,34,35 the MEMS group received 
training prior to starting the text-messages with the study interventionist (see supplemental 
methods for training details).  
Participants in MEMS received three sets of text-messages each weekday through 
TextIt’s50 secure web-based text-messaging service. Text-messages were sent during three 
specified time blocks: 1) 8:30–10:30 am, 2) 11:30 am–1:30 pm, and 3) 5:30–7:30 pm. 
Participants were asked to identify when they wanted to start receiving messages in each time 
block. Participants were informed that the interventionist may have a delayed response to text-
messages sent outside the time blocks. Following prior technology-based research with people 
with SMI,51 efforts were made to create text-messages that required a low reading level and used 
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concrete language. Calls to participants were made only if the participant did not reply to any 
text-messages for three consecutive days.   
Throughout an 8-week period, each MEMS participant received text-messages each 
weekday to reinforce and cue goal completion and to target effort-cost computations and future 
reward value representation maintenance. Messages occurred in the following order: 1) 
Reminder of the smaller sub-goal they set to complete that day, inquiry about how much effort 
they thought the goal would take to complete (scale 1–10), and then positive encouragement; 2) 
Encouragement that the sub-goal is worth the effort, and reminder of why the goal is valuable to 
them (based on information from the goal-setting session), and inquiry about when they thought 
they would complete the goal that day; 3) Assessment of sub-goal completion and how much 
effort it took to complete the goal (scale 1–10). If they did not complete the sub-goal, 
participants were asked what might help them reach their sub-goal, and whether the sub-goal 
could be broken down into smaller steps. If they did complete it, encouragement was provided to 
reinforce success and support adaptive effort-cost computations (i.e., if they overestimated the 
effort, then I reinforced that it was less effort then they thought it would be). At the end of each 
week, feedback indicating progress towards their overall goal was provided.    
Measures  
Participants were interviewed at baseline and follow-up by trained raters who were 
blinded to study condition. Brief measure descriptions are below (see supplemental methods for 
additional measure information). 
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Primary Outcome Measures.  
Interviewer-Rated Motivation. Interviewer-rated motivation was assessed by the 
aforementioned CAINS four motivation items and the three-item Motivation Index52 from 
Heinrich’s Quality of Life Scale (QLS53). Given that prior work has also found that the single 
motivation item form the QLS Motivation Index is a valid stand-alone measure of motivation,54 I 
also used this item in exploratory analyses.  
Subjective Motivation. Subjective motivation was assessed by the 6-item motivation and 
effort subscale of the self-report Motivation and Pleasure Scale (MAP-SR55). 
Effort-cost computations. Effort-cost computations were assessed by the aforementioned 
EEfRT,19 a 20-minute computerized paradigm consisting of trials where participants choose to 
complete either an easy or hard task after being informed of the associated monetary rewards for 
both options and probability of reward receipt.  
Value Representations of Future Rewards. Value representations of future rewards were 
measured using a delay-discounting task56  where participants choose between either a smaller 
immediate monetary reward or a larger delayed reward in 27 trials.  
MEMS Usability and Satisfaction. MEMS usability and satisfaction was assessed with 14 
self-report items based on the Usability, Satisfaction, and Ease of Use questionnaire.57  
Secondary Outcomes.  
Functioning. Functioning was assessed by the 9-item interviewer-rated Strauss-Carpenter 
Level of Function scale.58,59  
Quality of Life. Quality of Life was measured by the self-report overall quality of life 
item from the World Health Organization Quality of Life BREF scale (WHOQOL-BREF60). 
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Neurocognition. Neurocognition was measured using the brief neurocognitive assessment 
(BNA61,62).  
Additional Negative Symptoms. Additional negative symptoms were measured with the 
CAINS. Specifically, I measured anticipatory pleasure (i.e., expected pleasure for the upcoming 
week), past week pleasure, expressive symptoms, and overall negative symptoms.  
Positive and Mood Symptoms. Positive and Mood Symptoms were assessed with the 
widely-used interviewer-rated Positive and Negative Syndrome Scale (PANSS63).  
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ANALYSES  
Although intent-to treat analyses were planned, three people did not complete the study 
(see below) and follow-up data was not available. For hypothesis testing, I used a full analysis 
set,64 including data from all randomized participants with available data, regardless of actual use 
or adherence to the intervention. After variables were examined to ensure they met statistical 
assumptions, I first compared both groups on baseline demographics using independent samples 
t-tests and chi-square tests. Second, to assess MEMS feasibility and engagement, I examined 
text-message response rates, while descriptive statistics were used to assess responses to MEMS 
usability and satisfaction questions. Next, I used a series of one-way Analysis of Covariances 
(ANCOVAs) to assess whether there were group differences (randomized group served as the 
fixed factor) on primary and secondary outcomes at follow-up after co-varying for the associated 
baseline outcome level and if necessary, any identified group demographic differences. Given 
that neurocognition can impact motivation in schizophrenia,52,65 I re-ran all ANCOVA’s 
controlling for neurocognition; results were nearly identical so are not presented. To compare 
overall goal attainment between groups, I used independent samples t-tests. Finally, to identify 
whether MEMS engagement (text-message response rate) was related to changes in outcomes, 
correlations between MEMS response rate and outcome change scores (baseline minus follow-up 
score) were conducted. Effect sizes were based on Cohen’s d66 where 0.20 is small, 0.50 is 
medium, and 0.80 is large. 
  
21 
 
RESULTS 
Recruitment and Participant Characteristics  
One hundred participants were assessed for eligibility and 56 were randomized (27 to 
MEMS, 29 to control). As seen in the consort diagram (Figure 1), three participants (5.4%) did 
not complete the study. In the MEMS group, one participant self-withdrew several weeks after 
starting the text-messages because she obtained a job and did not think she would have time for 
the text-messages, while another was administratively withdrawn after the participant broke her 
phone prior to beginning the text-messages and then became unreachable. One participant in the 
control condition was unreachable at follow-up.   
At baseline, groups did not significantly differ on any demographic variable or CAINS 
motivation (see Table 1). Further, study non-completers (n = 3) and completers (n = 53) did not 
significantly differ on demographics or CAINS motivation. Across both conditions, participants 
were predominately African American (n = 39, 69.6%) and male (n = 29, 51.8%). Participants 
had a mean age of 46.1 (SD = 8.8) and had completed a mean of 11.8 (SD = 2.4) years of school. 
Most had unlimited text-messaging (n = 54, 96.4%) and had sent text-messages on their personal 
cell-phone prior to the study (n = 52, 92.9%). Mean chlorpromazine equivalent doses were 513.6 
(SD = 472.0), and CAINS motivation deficits were moderate (Mean = 7.6, SD = 2.3).  
MEMS Feasibility, Engagement, Usability, and Satisfaction  
MEMS Feasibility and Engagement 
Over the 8-week text-message period, participants received an average of 207.5 (SD = 
62.4) text-messages from the trial interventionist and sent an average of 185.8 (SD = 92.6) text-
messages to the interventionist. The average participant response rate was 86.1% (SD = 16.7%). 
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One participant responded to 18.5% of the text-messages, 3 responded to 63.1% to 73.3%, 9 
responded to 80 to 89.4%, and the remaining 12 responded to over 93% of the text-messages.  
Usability and Satisfaction 
See Table 2 for individual item responses. In terms of usability, 96% (n = 24) of MEMS 
participants reported they learned the mobile intervention quickly and it was easy to use. Sixteen 
percent (n = 4) reported difficulties understanding the text-messages and typing their responses, 
and 12% (n = 3) reported difficulties operating their phone. Regarding satisfaction, all 
participants reported they were satisfied with the text-messages, and 92% (n = 23) reported that 
the text-messages were useful and helped them to become more motivated. Ninety-two percent 
(n = 23) reported that the text-messages helped them to reach their goals and become more 
productive. Several participants also made unprompted comments via text-messages about how 
MEMS helped them (See supplemental Table 1).  
Preliminary Effectiveness  
Primary Outcomes. Consistent with my hypothesis, significant medium-sized group 
effects were found for CAINS motivation (F(1, 50) = 4.73, p = .03, d = -.58) (see Table 3), with 
MEMS participants demonstrating greater 8-week motivation than controls after controlling for 
baseline levels of CAINS motivation. No significant group effects were found for the QLS-
Motivation Index (F(1, 50) = 2.23, p = .14, d = .41), but exploratory analyses identified that the 
MEMS group had greater 8-week scores on the motivation item of the index than the control 
group after adjusting for pre-test motivation index item scores (F(1, 50) = 4.59, p = .04, d = .58); 
effect size was medium. As hypothesized, MEMS participants reached significantly more overall 
goals over eight-weeks than controls (t(51) = 3.82, p < .001, d = 1.06), with a large effect size. 
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Contrary to hypotheses, no significant group effects were found for subjective motivation (F(1, 
50) = .26, p = .61, d = -.14), value representations of future rewards (F(1, 50) = .96, p = .33, d = -
.27), or effort-cost computations  (F(1, 50) = .15, p = .70, d = -.11); however, several participants 
demonstrated fixed responses on the EEfRT (n = 9) or fixed or inconsistent responses56,67 on the 
delay discounting task (n = 7) (results were statistically the same when these participants were 
removed).  
Secondary Outcomes 
After controlling for baseline levels, follow-up anticipatory pleasure was significantly 
higher in the MEMS group compared to the control group (F(1, 50) = 5.93, p = .02, d = -.66), 
with a medium effect size (See supplemental Table 2). There was also a trend towards lower 8-
week overall negative symptoms (F(1, 50) = 3.42, p = .07, d = -.50) and higher 8-week pleasure 
in the past week (F(1, 50) = 2.87, p = .096, d = -.46) in the MEMS relative to the control 
condition after adjusting for the corresponding baseline score. There were no significant group 
differences for expressive negative symptoms (F(1, 50) = .26, p = .62, d = -.14), positive 
symptoms (F(1, 50) = .02, p = .89, d = -.04), mood symptoms (F(1, 50) = .01, p = .94, d = -.02), 
neurocognition (F(1, 50) = .12, p = .73, d = -.10), quality of life (F(1, 50) = .08, p = .78, d = -
.07), or functioning (F(1, 50) = .11, p = .74, d = .09).  
MEMS Engagement and Outcome Change 
Greater engagement (i.e., a higher text-message response rate) was associated with 
greater change (i.e., more improvement) in effort-cost computations (r(23) = -.61, p = .001), 
overall negative symptoms (r(23) = .40, p = .046), and anticipatory pleasure (r(23) = .43, p = 
.03). No other correlations were significant (See supplemental Table 3).  
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DISCUSSION 
Motivation deficits are a significant unmet treatment need in schizophrenia.9 The main 
aim of this study was to test the feasibility and preliminary effectiveness of a translational 
intervention that leverages mobile technology and recent findings in basic and behavioral 
schizophrenia research to create a novel, mechanism-based treatment for motivation deficits. 
These results suggest that not only is MEMS feasible but also is more effective than a single 
goal-setting session in several domains: interviewer-rated motivation and anticipatory pleasure as 
well as recovery-oriented goal attainment. Notably, to my knowledge, this study is also the first 
randomized trial demonstrating the feasibility of solely using participants’ personal cell-phones 
(rather than study provided cell-phones) to deliver a more ecologically valid and interactive text-
message intervention to target symptoms in people with schizophrenia.  
I also found that the MEMS intervention itself was highly engaging for most participants. 
Over the 8-week intervention period, the retention rate for the MEMS group was 92.6%, which is 
higher than rates around 70-80% found in several other text-message intervention studies for 
schizophrenia.34,37,39 This is particularly noteworthy given that all participants demonstrated at 
least moderate baseline motivation deficits. Further, similar to prior text-message intervention 
studies in schizophrenia,34,35 the overall mean response rate for MEMS was 86.1%. In addition, 
all participants reported being satisfied with the text-messages, and almost all participants (96%) 
reported that the text-messages were useful and helped them to become more motivated, that 
they learned to use the intervention quickly, and that MEMS was easy to use. Several 
participants also provided unprompted feedback via text-messages stating that the text-messages 
were encouraging, motivating, and helpful. Together, these results add to the growing literature 
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suggesting that text-message interventions are feasible and acceptable for most people with 
schizophrenia-spectrum disorders.42,68  
Notably, this study extends prior work by demonstrating that personal cell-phones are a 
feasible as well as clinically useful conduit for interactive text-messaging interventions. In 
screening 100 clients, only a few (9%) did not have text-message enabled cell-phones. This 
largely aligns with recent findings that approximately 72-81.4% of people with a psychotic 
disorder own a cell-phone.69,70 Further, all 56 participants who met eligibility criteria prior to 
randomization had agreed to receive text-messages to their personal cell-phone for 8-weeks, and 
92.9% had sent text-messages before the study. Phone service interruptions over the 8-weeks 
also appeared to be low (based on the MEMS response rate of 86.1%). Finally, although I 
reimbursed participants for text-message costs, almost all had unlimited text-messaging as part 
of their service plan, suggesting that reimbursement may not be necessary in future studies. 
Together, along with a meta-analysis showing that rates of cell-phone ownership among those 
with SMI appear to be increasing,69 these findings suggest that it is possible to leverage existing 
personal cell-phones for mobile interventions. Being able to use existing mobile devices may 
help to address concerns about ecological validity, scalability, sustainability, and implementation 
of mobile health text-message interventions in real-world clinical settings.71-73  
Importantly, this study also builds on feasibility and acceptability studies by using a 
randomized design with an active control group, to more rigorously test the preliminary 
effectiveness of MEMS. Results demonstrated that MEMS led to greater improvement in 
interviewer-rated motivation and anticipatory pleasure as well as recovery-oriented goal 
attainment compared to a goal-setting alone session, with medium to large effect sizes. These 
findings are important given that there are few, particularly brief treatments (i.e., less than 18 
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months) that have demonstrated efficacy for improving the domains of motivation and 
anticipatory pleasure. 
Yet the impact was not universally positive. I found no advantage of MEMS for effort-
cost computations, value representations of future rewards, or self-reported motivation. The lack 
of findings for the performance-based tasks was particularly surprising because these were the 
targeted mechanisms by which I expected motivation to improve. I speculate that the lack of 
improvement on both performance-based tasks may be due to near ceiling level or fixed 
responses at baseline for several participants. Alternatively, it may be that these measures did not 
effectively represent the constructs that I was targeting in MEMS (e.g., were too different or 
distal) or that the tasks may have been “too easy” for some participants, particularly in 
comparison to real-world goal behaviors that often require higher effort than button presses over 
a longer period of time than a single 20-minute session. Further, in both performance-based 
tasks, the rewards were monetary and relatively small (particularly in the EEfRT), and the 
subjective value of money or rewards can vary across people or time-points (i.e., distance from 
paycheck).13,74 Further, monetary rewards likely do not facilitate the same motivational response 
and require a less complex and abstract mental representation than rewards such as pleasure or a 
sense of accomplishment that are associated with completing real-world goals. Indeed, although I 
chose these performance-based measures because they have been described as putative objective 
measures of both effort-cost computations and future reward-value representation maintenance, 
more recent work has found little overlap between the EEfRT and motivation measures like the 
CAINS and QLS–Motivation Index,75 suggesting that they may be measuring disparate 
constructs. To better assess mechanisms of MEMS improvement and to more precisely identify 
whether effort-cost computations and future reward-value representation maintenance are 
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effective treatment targets to enhance motivation, future work could use more recently developed 
performance-based effort-based decision-making measures, such as effort discounting tasks,76 
which have shown greater concordance with motivation/negative symptom measures.75 
In terms of secondary outcomes, there were significantly greater improvements in 
anticipatory pleasure in MEMS compared to the control group (medium effect size). Further, 
both overall negative symptoms and pleasure in the past week trended towards greater 
improvement in MEMS relative to the control group. It may be that as participants worked more 
regularly towards their goals or had more success attaining sub-goals, they also had greater 
anticipated as well as experienced enjoyment for goal-related activities. Further, the text-
message reminders about why the sub-goals were worth the effort and valuable could have 
helped the participants to more readily represent future rewards (e.g., pleasure) as well as 
strengthen the mental link between sub-goal completion and future rewards.30 Alternatively, the 
reinforcement provided in the text-messages after successful goal attainment could also have led 
to increased instances of pleasure. Additional work is needed to parse out the mechanisms of 
improvements. However, there were no significant improvements in the additional secondary 
outcomes of interviewer-rated symptoms (positive, mood, and expressive symptoms), 
neurocognition, self-reported quality of life, or interviewer-rated functioning in the MEMS group 
compared to the goal-setting alone group. This may be due to the low-intensity nature or length 
of MEMS, which likely limited my ability to detect whether the effects of MEMS would 
translate into these more distal symptoms or broader, longer-term outcomes such as functioning 
and quality of life.  
I also explored whether greater engagement in MEMS (i.e., a higher text-message 
response rate) was linked to greater improvements in my primary and secondary outcomes. 
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Results revealed that greater engagement in MEMS was associated with greater improvement in 
effort-cost computations, anticipatory pleasure, and overall negative symptoms. In terms of 
effort-cost computations, this may suggest that only those with higher MEMS engagement saw 
improvements on this measure. Alternatively, it may also be that the goal-setting session and 
breaking down overall goals into daily sub-goals helped to improve effort-cost computations in 
both groups, which obscured the additional benefits of MEMS on effort-cost computations when 
conducting the group comparisons. Future studies with larger samples may be beneficial in 
clarifying the impact of MEMS on effort-cost computations. Relatedly, I did not observe that 
greater MEMS engagement was significantly associated with greater improvements in 
interviewer-rated motivation; however, the magnitude of the correlations between engagement 
and interviewer-rated motivation on the CAINS and QLS motivation item was small to medium, 
suggesting that I may have been underpowered to detect significant effects. On the other hand, 
given that greater MEMS engagement was associated with greater change in anticipatory 
pleasure, it may suggest that the content of the text-messages had a relatively stronger impact on 
anticipatory pleasure rather than on motivation. Future work could examine what level and 
length of MEMS engagement is needed to produce significant changes in these domains.  
Consistent with prior text-message intervention studies,34,35 these results suggest that 
MEMS may not be suitable for all people with schizophrenia-spectrum disorders. Even after a 
text-message training session, I found that a few participants had difficulties typing their 
responses, operating their phone, and/or understanding the text-messages. Some participants may 
need additional training in order to better engage with mobile interventions. Similarly, although 
further work is needed to identify how to best integrate mobile services within current caseloads 
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and models of care,71 it may also be that additional, regular support from a community-based 
clinician may help to reduce difficulties with mobile interventions.  
There were also several limitations that should be considered when interpreting these 
findings. First, although a strength of this study was that I used a randomized design, I was not 
able to examine whether improvements in the MEMS group were maintained after the 
intervention period. Second, while the sample size was similar or even larger than many prior 
text-message studies,35,37,77 my sample was still relatively small and may have been 
underpowered to detect some effects. A third limitation is the use of personalized text-messages, 
which may impede widespread dissemination given the need for clinical personnel. However, 
more automated approaches could be attempted, and future studies could compare the efficacy of 
a completely automated approach to this more personalized approach.  
In conclusion, this study supports the feasibility and preliminary effectiveness of a 
translational intervention that uses text-messages to support motivation in real-time, real world-
settings among those with schizophrenia-spectrum disorders. Specifically, I found that those who 
received MEMS had greater improvements in interviewer-rated motivation and anticipatory 
pleasure compared to a goal-setting alone group. Moreover, MEMS participants successfully 
obtained significantly more recovery-oriented goals, including obtaining a part-time job, 
improving familial relationships, becoming healthier through regular exercise, or obtaining 
independent housing. Importantly, the majority of MEMS participants—all of whom began the 
study with at least moderate motivation deficits—were highly engaged in the intervention. 
Together, these findings support the feasibility and utility of leveraging personal cell-phones to 
deliver a more ecologically valid mobile intervention that may reduce one of the most 
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debilitating symptoms of schizophrenia and help participants attain more meaningful life-goals 
that support their recovery.  
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TABLES 
Table 1. Baseline Participant Demographics by Group 
 MEMS  
(n = 27)  
Goal-Setting 
Alone  
(n = 29)  
Test of significance 
 n, % n, %  
Diagnosis   X2 (1) = .25 
Schizophrenia 12, 44.4% 11, 37.9%  
Schizoaffective disorder 15, 55.6% 18, 62.1%  
Gender (n, % Female) 15, 55.6% 12, 41.4% X2 (1) = 1.13 
Race    X2 (2) = .78 
African American 18, 66.7% 21, 72.4%  
White 8, 29.6% 6, 20.7%  
Other or multiple races 1, 3.7% 2, 6.9%  
Sent text-messages prior to study 26, 96.3% 26, 89.7% X2 (1) = .93 
Unlimited text-message plan 26, 96.3% 28, 96.6% X2 (1) = .003 
 M SD  
Age 46.0 (10.0) 46.3 (7.7) t (54) = -.12 
Education  12.0 (2.7) 11.7 (2.0)  t (54) = .35 
Chlorpromazine Equivalent Dosesa 618.3 (544.6) 416.1 (376.5) t (54) = 1.63 
Length of Illness 24.0 (12.1) 23.4 (10.5) t (52) = .21 
CAINS – Motivation 7.7 (2.6) 7.5 (1.9) t (54) = .30 
Note. CAINS = Clinical Assessment Interview for Negative Symptoms.  
aBased on78-80  
 
  
Table 2. Usability and Satisfaction for MEMS Participants (n = 25) 
 Strongly 
Disagree 
Disagree Disagree 
Somewhat 
Neutral  Agree 
Somewhat 
Agree Strongly 
Agree 
Usability items         
I learned to use the mobile intervention 
quickly.  
0 1 (4%) 0 0 4 (16%) 8 (32%) 12 (48%) 
The mobile intervention was easy to use.  1 (4%) 0  0  0  1 (4%) 12 (48%) 11 (44%) 
The mobile intervention did everything I 
would expect it to. 
0 0 0 3 (12%) 4 (16%) 8 (32%) 10 (40%) 
I had difficulties typing my responses. 14 (56%) 3 (12%) 1 (4%) 3 (12%) 2 (8%) 0  2 (8%) 
I had difficulties operating my phone. 15 (60%) 4 (16%) 1 (4%) 2 (8%) 1 (4%) 2 (8%) 0  
I had difficulties understanding the text 
messages. 
16 (64%) 2 (8%) 2 (8%) 1 (4%) 0  2 (8%) 2 (8%) 
The text messages interfered with my 
daily activities. 
17 (68%) 3 (12%) 1 (4%) 2 (8%) 2 (8%) 0  0  
Satisfaction items         
The text-messages I recevied were 
useful. 
0  0  0  1 (4%) 1 (4%) 7 (28%) 16 (64%) 
I was satisfied with the text-messages I 
received.a  
0 0 0 0 2 (8%) 4 (16%) 18 (72%) 
I would be interested in participating in 
similar studies in the future.  
0 0 0 0 0 6 (24%) 19 (76%) 
I would recommend to others that they 
should participate in a similar study.  
0 0 0 0 2 (8%) 7 (28%) 16 (64%) 
The text-messages helped me to reach 
my goal(s).  
0 0 0 2 (8%) 2 (8%) 6 (24%) 15 (60%) 
The text-messages helped me to be more 
productive.  
0 0 1 (4%) 1 (4%) 2 (8%) 5 (20%) 16 (64%) 
The text-messages helped me become 
more motivated.a  
0 0 0 1 (4%) 2 (8%) 7 (28%) 14 (56%) 
a n = 1 (4%) missing data for this item. 
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Note. Descriptive statistics are simple statistics without co-varying for baseline level of variable; CAINS = Clinical Assessment Interview 
for Negative Symptoms; MAP-SR = Motivation and Pleasure Self-Report; QLS = Quality of Life Scale.  
a Results based on those who completed both assessment points.  
b t-value and associated significance test and effect size are reported.  
c Effect sizes were calculated with adjusted follow-up means and pooled standard deviations for all but goal attainment where effect sizes 
were based on follow-up means and pooled standard deviations. 
 
 
 
 
  
Table 3. Measure Descriptive Statistics and Group Effects for Primary Outcomes 
 MEMS  Goal-Setting Alone Fa p dc 
 BL 
(n = 27) 
8-week 
(n = 25) 
BL 
(n = 29) 
8-week 
(n = 28) 
   
Measure M (SD) M (SD) M (SD) M (SD)    
CAINS – Motivation 7.7 (2.6) 6.2 (2.5) 7.5 (1.9) 7.4 (2.7) 4.73 .03 -.58 
QLS – Motivation index 8.0 (2.5) 9.6 (3.8) 7.4 (2.8) 8.0 (3.5) 2.23 .14 .41 
QLS – Motivation item 2.5 (1.3) 3.6 (1.4) 2.3 (1.1) 2.9 (1.3) 4.59 .04 .58 
MAP-SR – Motivation 11.2 (5.4) 11.6 (5.6) 7.9 (5.0) 10.3 (6.5) .26 .61 -.14 
Overall goals obtained - %  – 77.6 (26.7) – 46.7 (31.6) 3.82b < .001 1.06 
Value representation maintenance – % 
Delayed rewards  
35.7 (21.2) 32.7 (19.2) 28.6 (23.0) 30.3 (25.4) .96 .33 -.27 
Effort-Cost Computations - % Hard 
chosen in 88%, high reward trials  
45.9 (32.4) 42.0 (35.5) 36.6 (29.2) 38.9 (36.4) .15 .70 -.11 
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FIGURE 
 
Figure 1. Consort Flow Diagram  
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APPENDIX A. SUPPLEMENTAL METHODS  
RANDOMIZATION. Randomization was conducted using a random number generator 
in blocks of 10; each block had an equal number of both conditions. Randomization codes were 
generated by an independent researcher and sealed in envelopes with consecutive numbers; these 
were opened in ascending order during randomization. 
TEXT-MESSAGE TRAINING. First, the limits of text-message confidentiality and 
ways to improve privacy (e.g., adding an access password) were reviewed. Next, participants 
were trained to send and receive text-messages and modify relevant settings (e.g., text-message 
notification volume, text font size) on their personal phone. Participants then engaged in a 
practice text-messaging session where they drafted and sent a message and opened and read a 
received message from the study interventionist.  
 GOAL-SETTING SESSION. Goals could be set in any domain, but participants were 
first asked if they wanted to make changes in the domains identified as reduced on the CAINS 
motivation items. Using GCT and information gathered in the assessments, attempts were made 
to help participants integrate information to accurately identify and assess the value, effort, and 
probability of attaining an identified goal. Identified goals were translated into a SMART goal, 
and participants discussed and then rated the value/importance of the goal (rated from 1–10), 
effort to complete the goal (rated from 1–10), and the participant’s confidence in completing the 
goal (rated 0–100%) (a copy of this information was provided to participants). To further 
overcome effort-cost computation difficulties, each overall goal was collaboratively broken 
down into smaller sub-goals to complete each week-day over 8-weeks; sub-goals were written on 
calendars, and participants were instructed to mark a box in the corner of the calendar to indicate 
when they completed the sub-goal.  
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MEASURES  
INTERVIEWER-RATED MOTIVATION. The Clinical Assessment Interview for 
Negative Symptoms (CAINS)47 motivation items assess motivation over the past week for the 
domains of family, close friends and romantic relationships, work and school, and recreational 
activities. The motivation index53 items assess a person’s global degree of motivation to initiate 
and sustain activities, curiosity in daily life, and sense of purpose or having integrated, realistic 
life goals over the preceeding four weeks.  
SUBJECTIVE MOTIVATION. The Motivation and Pleasure Scale (MAP-SR55) 
motivation and effort subscale items assess perceived motivation and effort over the past week 
for social, work, school, hobbies, and recreational acitivities. 
Effort-Cost Computations. On the Effort Expenditure for Rewards Task (EEfRT19), easy task 
rewards are always $1.00, while hard tasks rewards vary from $1.24-$4.12. The probability of 
reward receipt if the chosen task is completed varies (but is the same for each trial option), 
ranging from high (88%), medium (50%), to low (12%). The easy task asks participants to make 
30 button presses in 7 seconds using their dominant hand index finger, and the hard task requires 
100 button presses in 21 seconds with their non-dominant hand pinky finger. Participants are 
instructed that earnings from the task are based on two randomly selected tasks. Following prior 
methods,23 our main effort-cost computations outcome was the percentage of hard trials selected 
in the high reward (≥ $3.01) high probability (88%) trials. 
VALUE REPRESENTATIONS OF FUTURE REWARDS. On the delay-discounting 
task,56 small rewards range from $11-80, while larger delayed rewards range from ($25-85). 
Delays range from seven to 186 days. As studies have failed to find performance differences 
between hypothetical and real monetary rewards,81,82 participants were informed that they would 
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not receive the rewards but should make their decisions as if the rewards were genuine. 
Following Myersen et al.,83 greater ability to represent the value of a future reward was indexed 
by the percentage of larger delayed rewards selected. 
MEMS USABILITY AND SATISFACTION. Items were based on the Usability, 
Satisfaction, and Ease of Use Questionnaire, which was previously modified to assess the 
usability and satisfaction of a mobile intervention in a schizophrenia-spectrum sample.35 
Functioning. The Strauss-Carpenter Level of Function Scale58,59 contains items that assess social 
contacts, work, symptoms, and general functioning over the past month. 
Quality of life. The World Health Organization Quality of Life Bref scale (WHOQOL-BREF60) 
is based on past 2 weeks.  
NEUROCOGNITION. The updated brief neurocognitive assessment (BNA61,62) 
assesses working memory with the letter-number sequencing test84 and processing speed with the 
symbol coding subtest from the brief assessment of cognition in schizophrenia (bacs85). 
Following Fervaha et al.,61 I created an overall BNA standardized z-score based on normative 
data.  
ADDITIONAL NEGATIVE SYMPTOMS. Anticipatory pleasure was measured with 
the three CAINS items assessing expected pleasure for the upcoming week for the domains of 
social relationships, work and school, and recreational activities; the CAINS was also used to 
assess past week pleasure (3 items) for the same domains. Emotion expression and speech were 
assessed with the four expressive items (facial expression, vocal expression, expressive gestures, 
quantity of speech). Finally, overall negative symptoms were assessed with the CAINS total 
score. 
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POSITIVE AND MOOD SYMPTOMS. I assessed positive and emotional discomfort 
(mood) symptoms following factor-analytically derived factors86 on the positive and negative 
syndrome scale (PANSS63). 
  
APPENDIX B. SUPPLEMENTAL TABLES 
 
 
 
Supplemental Table 1. Unprompted MEMS Participant Feedback Sent Via Text-Messages 
Participant ID Feedback  
108 This has really helped me this study it gave me reason to keep going and not give up. 
110 Tu i have never been able tn do this before and all of a sudden i can. 
126 I like this study. I wish someone could always work with me on goals like this its helpful.  
141 I not only learned but enjoyed this. It makes me better. My goals are getting into focus. 
144 Your texts were very helpful motivating me 2 get things done.  
148  Thank you very much for everything you have done to encourage me… I think I have learned what I am capable 
of doing. I just scared of doing it without your morning text-reminders of encouragement….Yet, I know what 
you are going to say, “NAME, you can do it. That’s right: “I can do it.” 
164 Having the text reminders in the a.m. has been helpful. 
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Note. Descriptive statistics are simple statistics without co-varying for baseline level of variable; BNA = brief neurocognitive 
assessment; CAINS = Clinical Assessment Interview for Negative Symptoms; PANSS = Positive and Negative Syndrome Scale; 
WHOQOL = World Health Organization Quality of Life; QLS = Quality of Life Scale; QOL = quality of life.  
a Results based on those who completed both assessment points.  
c Effect sizes were calculated with adjusted follow-up means and pooled standard deviations.  
 
 
 
 
 
 
  
 
Supplemental Table 2. Measure Descriptive Statistics and Group Effects for Secondary Outcomes 
 MEMS Goal-Setting Alone Fa p db 
 BL 
(n = 27) 
8-week 
(n = 25) 
BL 
(n = 29) 
8-week 
(n = 28) 
   
Measure M (SD) M (SD) M (SD) M (SD)    
CAINS – Anticipatory pleasure 6.8 (3.3) 5.3 (2.5) 7.8 (2.8) 7.2 (2.5) 5.93 .02 -.66 
CAINS – Past week pleasure 3.6 (2.3)  2.6 (1.9) 4.0 (2.0) 3.4 (1.4) 2.87 .096 -.46 
CAINS – Expressive symptoms 5.1 (3.3) 4.4 (3.9) 6.0 (4.0) 5.2 (3.4)  .26 .62 -.14 
CAINS – Overall negative symptoms 23.2 (7.6) 18.4 (8.5) 25.3 (6.0) 23.3 (7.7) 3.42 .07 -.50 
PANSS – Positive symptoms 3.2 (.9) 2.7 (1.0) 2.9 (.8) 2.5 (.8) .02 .89 -.04 
PANSS – Mood symptoms 3.3 (1.1) 3.0 (1.2) 3.0 (1.1) 2.9 (1.1) .01 .94 -.02 
BNA – Neurocognition  -1.7 (1.2) -1.7 (1.0) -1.8 (1.1) -1.6 (1.0) .12 .73 -.10 
WHOQOL – Overall QOL  3.4 (1.0) 3.6 (1.0) 3.2 (1.2) 3.6 (1.0) .08 .78 -.07 
Strauss-Carpenter – Functioning  16.9 (5.5) 19.4 (4.5) 17.0 (4.8) 19.0 (4.8) .11 .74 .09 
 
4
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Supplemental Table 3. Correlations between MEMS Engagement and 
Outcome Change (n = 25) 
Measure r 
CAINS – Motivation .20 
QLS – Motivation index -.07 
QLS – Motivation item -.28 
MAP-SR – Motivation -.31 
Value Representation Maintenance – % Delayed rewards  -.26 
Effort-Cost Computations - % Hard chosen in 88%, high 
reward trials  
-.61** 
CAINS – Anticipatory pleasure .43* 
CAINS – Past week pleasure .21 
CAINS – Expressive symptoms .21 
CAINS – Overall negative symptoms  .40* 
PANSS – Positive symptoms -.09 
PANSS – Mood symptoms -.06 
BNA – Neurocognition  -.17 
WHOQOL – Overall QOL  -.24 
Strauss-Carpenter – Functioning  -.09 
Note. BNA = Brief Neurocognitive Assessment; CAINS = Clinical Assessment Interview for 
Negative Symptoms; MAP-SR = Motivation and Pleasure Self-Report PANSS = Positive and 
Negative Syndrome Scale; WHOQOL = World Health Organization Quality of Life; QLS = 
Quality of Life Scale; QOL = quality of life.  
For CAINS and PANSS, positive correlation = higher response rate associated with greater 
reduction in symptoms. For other measures, negative correlation = higher response rate is 
associated with greater improvement in measure.  
*p < .05, **p < .01.  
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